Aixin Li

1.2k total citations
33 papers, 526 citations indexed

About

Aixin Li is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Aixin Li has authored 33 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Aixin Li's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Aixin Li is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Aixin Li collaborates with scholars based in China, United States and Germany. Aixin Li's co-authors include Ann Greer, Marco M. Gottardis, Joan M. Carboni, Ricardo M. Attar, Xiaojie Huang, Jianhua Hou, Mark D. Wittman, Francis Y. Lee, Dolatrai M. Vyas and Upender Velaparthi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Aixin Li

33 papers receiving 514 citations

Peers

Aixin Li
Shirish Paranjpe United States
Richard de Boer Netherlands
Jie Lin China
Frank Rohde Germany
Michael Cooreman United States
Shirish Paranjpe United States
Aixin Li
Citations per year, relative to Aixin Li Aixin Li (= 1×) peers Shirish Paranjpe

Countries citing papers authored by Aixin Li

Since Specialization
Citations

This map shows the geographic impact of Aixin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixin Li more than expected).

Fields of papers citing papers by Aixin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixin Li. The network helps show where Aixin Li may publish in the future.

Co-authorship network of co-authors of Aixin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Aixin Li. A scholar is included among the top collaborators of Aixin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixin Li. Aixin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Weijun, Wenjing Wu, Qiao Yang, et al.. (2024). The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation. Journal of Biological Chemistry. 300(3). 105671–105671. 2 indexed citations
2.
Li, Aixin, Qian Wang, Peng Li, Na Zhao, & Zhaoguang Liang. (2023). Effects of green tea on lipid profile in overweight and obese women. International Journal for Vitamin and Nutrition Research. 94(3-4). 239–251. 7 indexed citations
3.
Lv, Shiyun, et al.. (2023). Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy. Infection and Drug Resistance. Volume 16. 4697–4706. 4 indexed citations
4.
Chu, Xianjing, et al.. (2023). Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial. iScience. 26(9). 107634–107634. 4 indexed citations
5.
Steffen, Brian T., James S. Pankow, Faye L. Norby, et al.. (2022). Proteomics Analysis of Genetic Liability of Abdominal Aortic Aneurysm Identifies Plasma Neogenin and Kit Ligand: The ARIC Study. Arteriosclerosis Thrombosis and Vascular Biology. 43(2). 367–378. 6 indexed citations
6.
Li, Aixin, Weijun Wu, Qiao Yang, et al.. (2022). Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment. Journal of Cancer. 13(15). 3606–3614. 2 indexed citations
7.
Li, Junhua, Fangming Yang, Minfeng Xiao, & Aixin Li. (2022). Advances and challenges in cataloging the human gut virome. Cell Host & Microbe. 30(7). 908–916. 24 indexed citations
8.
Zhao, Wen, et al.. (2021). Clinical Characteristics and Durations of Hospitalized Patients with COVID-19 in Beijing: A Retrospective Cohort Study. SHILAP Revista de lepidopterología. 6(1). 8 indexed citations
9.
Zhang, Ke, Yang Zhang, Xinchao Liu, et al.. (2021). Three-Drug Regimens Containing Integrase Inhibitor Show Good Efficacy and Safety in Treatment-Naive Patients With HIV-1: A Bayesian Analysis. Frontiers in Pharmacology. 12. 603068–603068. 8 indexed citations
10.
Li, Aixin, Jiming Yin, Xiaojie Huang, et al.. (2021). A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis. BMC Infectious Diseases. 21(1). 500–500. 4 indexed citations
11.
Liu, Tongtong, Xi Wang, Aixin Li, et al.. (2021). Service acceptance of HIV non-occupational post-exposure prophylaxis(nPEP) among college students: a cross-sectional study in China. BMC Public Health. 21(1). 1220–1220. 7 indexed citations
12.
Wu, Yaxin, Yang Zhang, Xinchao Liu, et al.. (2021). Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 12. 718763–718763. 16 indexed citations
14.
Qin, Yuanyuan, Xiaojie Huang, Hui Chen, et al.. (2020). Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis. BMC Infectious Diseases. 20(1). 551–551. 52 indexed citations
16.
Velaparthi, Upender, Mark G. Saulnier, Mark D. Wittman, et al.. (2010). Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one. Bioorganic & Medicinal Chemistry Letters. 20(10). 3182–3185. 16 indexed citations
17.
Huang, Fei, Ann Greer, Warren Hurlburt, et al.. (2008). The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors. Cancer Research. 69(1). 161–170. 137 indexed citations
18.
Saulnier, Mark G., David B. Frennesson, Mark D. Wittman, et al.. (2008). 2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924. Bioorganic & Medicinal Chemistry Letters. 18(5). 1702–1707. 20 indexed citations
19.
Zimmermann, Kurt, Mark D. Wittman, Mark G. Saulnier, et al.. (2008). Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4075–4080. 17 indexed citations
20.
Wittman, Mark D., Balu Balasubramanian, Upender Velaparthi, et al.. (2006). Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase. Bioorganic & Medicinal Chemistry Letters. 17(4). 974–977. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026